GlassScriptPhysician profile
Yuri C Lansinger
NPI 1295901692
$4,728.65
in general payments reported to CMS, 2019-2025
15 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,519 · 2020: $313 · 2021: $475 · 2022: $168 · 2023: $846 · 2024: $956 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,253.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,264.13 | 2019-2023 | Acumed |
| Axogen | $1,053.44 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Stryker Corporation | $658.79 | 2020-2024 | Gamma |
| Pylant Medical | $349.29 | 2019-2024 | |
| Skeletal Dynamics INC | $304.47 | 2019-2024 | Align, Implate, Geminus |
| Trimed, INC. | $229.65 | 2023 | |
| Kerecis Limited | $207.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $158.61 | 2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $147.13 | 2024 | Novosorb Btm |
| Checkpoint Surgical, INC | $81.05 | 2025 | Checkpoint Stimulators |
| Exsomed Corporation | $76.76 | 2019 | |
| Extremity Medical | $76.62 | 2021 | |
| P Bar Medical LLC | $61.84 | 2025 | |
| Smith+Nephew, INC. | $40.44 | 2024 | Ascension |
| Nalu Medical, INC. | $19.26 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuri Lansinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.